Key points are not available for this paper at this time.
Background/Aims: Irritable bowel syndrome (IBS) is a common disease often considered as a functional intestinal disorder. Inflammation in IBS is a quite intriguing theory. The aim of this study was to investigate tumor necrosis factor (TNF)-, interleukin (IL)-1 and IL-6 expression in inflammatory bowel disease (IBD) patients, IBS patients and normal controls. Methods: IBS and IBD patients along with normal controls were recruited in the study. In all groups, 2 pinch biopsies were taken at each of 3 anatomical sites (terminal ileum, cecum, and rectum). IBS patients were also subcategorized according to the syndrome clinical manifestations. Two monoclonal antibodies (mAb), TNF- mAb and IL-6 mAb, and one polyclonal antibody IL-1 mAb were applied for immunohistochemical analysis. Results: In IBD patients intensity of TNF- and IL-1 were lower than in IBS patients or controls, while IL-6 was significantly increased comparing to the aforementioned groups. In IBS patients TNF- was increased comparing to IBD patients or controls, while IL-6 and IL-1 were similar to controls. In IBS subgroups, TNF- was lower in diarrhea predominant IBS patients and higher constipation predominant IBS patients. Differences among IBS subgroups regarding IL-6 and IL-1 were nonsignificant. Conclusions: IL-6 seems to be the most important proinflammatory cytokine in IBD patients, while TNF- could play a more significant role in IBS pathogenesis. (
Mitselou et al. (2020) studied this question.